Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?
R/R International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B
Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurat" by Santosh Khanal, Arjun Gampala et al.
A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy
Follicular Lymphoma International Prognostic Index (FLIPI). Online calculator | ClinCaseQuest
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
Diffuse Large B-cell Lymphoma Prognosis Calculator
A prognostic gene signature for predicting survival outcome in diffuse large B-cell lymphoma - Cancer Genetics
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI in: Journal of the National Comprehensive Cancer Network Volume 13 Issue 12 (2015)
Overall survival of patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
Flowchart of the survival analysis of patients with diffuse large... | Download Scientific Diagram
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter? | Journal of Nuclear Medicine
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index | Journal of Clinical Oncology
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi | Journal of Clinical Oncology
How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis
Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
Overall survival curves of patients with primary gastric diffuse large... | Download Scientific Diagram
Gray Zone Lymphoma (GZL) with Features Intermediate between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective. - ppt download
H&E and immunohistochemical stain images of 209 cases of diffuse large B-cell lymphoma linked with cytogenetic features and clinical outcomes (DLBCL-Morphology) - The Cancer Imaging Archive (TCIA) Public Access - Cancer Imaging
